Evidence map›Paper›PMID 42309056›Full record

ArticleAmerican journal of human genetics2026

Complete chromosome 21 centromere sequencing of families with Down syndrome.

F Kumara Mastrorosa, Alessia Daponte, Luciana de Gennaro, Shu-Cheng Chuang, Jiadong Lin, Yang Sui, David Porubsky, Keisuke K Oshima, Julie Wertz, Allison N Rozanski and 18 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

F Kumara MastrorosaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Alessia DaponteDepartment of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, 70124 Bari, Italy.
Luciana de GennaroDepartment of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, 70124 Bari, Italy.
Shu-Cheng ChuangDepartment of Genetics, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jiadong LinDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Yang SuiDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
David PorubskyDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany.
Keisuke K OshimaDepartment of Genetics, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Julie WertzDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Allison N RozanskiDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
William T HarveyDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Yanni WangTerry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Tiffany Y LeungTerry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Daniel D ChanTerry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Weiya HeDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jordan KnuthDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Gage H GarciaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Marcelo AyllonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Katherine M MunsonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Kendra HoekzemaDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.
Peter M LansdorpTerry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Claudia Rita CatacchioDepartment of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, 70124 Bari, Italy.
Mario VenturaDepartment of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, 70124 Bari, Italy.
Stephanie L ShermanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Emily G AllenDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Tracie C RosserDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Glennis A LogsdonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; Department of Genetics, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: glogsdon@pennmedicine.upenn.edu.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA. Electronic address: ee3@uw.edu.

Funding

Identifying and Characterizing the Full Spectrum of Haplotype-resolved Structural Variation in Human GenomesU24HG007497 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Evan Eichler, Jan Oliver Korbel · 2019 to 2026
$17.2M
Sequence-resolved structural variation of human genomesR01HG010169 · NHGRI · UNIVERSITY OF WASHINGTON · PI Evan Eichler · 2018 to 2026
$4.5M
Human centromere variation and functionR00GM147352 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Glennis Amelia Logsdon · 2024 to 2026
$747k
NHGRI NIH HHS R01 HG010169NHGRI NIH HHS U24 HG007497NIGMS NIH HHS R00 GM147352
6 · The paper itself

Abstract

Down syndrome, the most common form of human intellectual disability, results from nondisjunction and an extra copy of chromosome 21 (chr21), also known as trisomy 21 (T21). Small centromeres have been hypothesized to contribute to its etiology, and studies on mice suggest that larger centromeres are more efficiently transmitted, yet complete sequencing of chr21 centromeres has been particularly challenging due to their repetitive nature and homology to chromosome 13. Using long-read sequencing, we sequenced and assembled the centromeres from eight families with a child with T21 (one parent-child trio, six mother-child duos, and one singleton), all resulting from maternal meiosis I errors. A comparison of all proband chr21 centromeres (n = 24) to those of control individuals (n = 287) shows that small centromeres are not enriched in families with T21 (p value = 0.72), contrary to earlier reports. However, chr21 extreme centromere size asymmetry (>10-fold) was observed for two of them. Mothers from these two families with T21 carry some of the smallest chr21 centromeres (143 and 181 kbp) observed in female individuals to date, exhibiting a ∼10.7- and ∼19.4-fold centromeric α-satellite higher-order repeat array size difference between the maternally inherited homologs, respectively. Phylogenetic reconstruction reveals that human chr21 is particularly prone to such asymmetry, with some of the biggest size differences occurring over the last ∼17,000 years of human evolution.

Indexed as

CentromereChromosomes, Human, Pair 21Down SyndromeChildFemaleHumansMalePedigreeSequence Analysis, DNAaneuploidycentromerecentromere asymmetrychromosome 21Down syndromegenome assemblyintellectual disabilitylong-read sequencingmethylationtrisomy 21

Identifiers

PMID42309056
PMCPMC13288774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.